Sensitivity as outcome measure of androgen replacement: the AMS scale
<p>Abstract</p> <p>Background</p> <p>The capacity of the AMS scale as clinical utility and as outcome measure still needs validation.</p> <p>Methods</p> <p>An open post-marketing study was performed by office-based physicians in Germany in 2004....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | Health and Quality of Life Outcomes |
Online Access: | http://www.hqlo.com/content/4/1/23 |